Cohance Lifesciences Limited (BOM:543064)
India
· Delayed Price · Currency is INR 542.20
-6.90 (-1.26%)
At close: Dec 5, 2025
Cohance Lifesciences Revenue
Cohance Lifesciences had revenue of 5.56B INR in the quarter ending September 30, 2025, with 115.57% growth. This brings the company's revenue in the last twelve months to 12.11B, up 25.95% year-over-year. In the fiscal year ending March 31, 2025, Cohance Lifesciences had annual revenue of 11.98B with 13.91% growth.
Revenue (ttm)
12.11B
Revenue Growth
+25.95%
P/S Ratio
17.15
Revenue / Employee
9.99M
Employees
1,212
Market Cap
207.56B
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Reliance Industries | 9,996.29B |
| HDFC Bank | 2,683.70B |
| Bharti Airtel | 1,946.14B |
| Tata Consultancy Services | 2,576.88B |
| ICICI Bank | 1,909.34B |
| State Bank of India | 3,571.95B |
| Infosys | 1,748.84B |
| Bajaj Finance | 406.39B |